Nordic Pharma and Harrow partnered to launch an authorized generic of Maxitrol, Nordic President Philip Gioia said in this ...

Two novel agents targeting angiopoietin-like protein 3 demonstrated safety and lipid-lowering capabilities in phase 2 trials, ...

Amid cuts to and cancellation of U.S. public health programs aimed at treating and preventing malaria infection, officials ...

Simulation software designed to build a virtual eye may help predict the outcomes of laser vision correction before surgery, ...

Results of a survey conducted among ophthalmic industry, administrators and surgeons revealed that industry representatives ...

A bill recently passed by the West Virginia legislature would undo the state’s mandate for newborns to receive prophylaxis ...

“National Shoulder and Elbow Week is very much a grassroots effort with grassroots appeal, because it is held locally in ...

More than 8,500 physicians are attending PAS 2025 — the largest turnout at the annual pediatrics conference since 2018, ...

The representation of Black and Asian adults is on the rise in atopic dermatitis clinical trials, according to a study. As ...

A new core curriculum specifically for advanced practice providers, or APPs, is under development to fill a gap in the field ...

The FDA has granted clearance to TytoCare’s AI-powered Tyto Insights for Lung Sounds to detect rhonchi, marking the third ...

A multidisciplinary team of researchers at University of Cincinnati Cancer Center is conducting a clinical trial to identify ...